Methylphenidate: New Information and New Options

Marcia L. Buck, Pharm.D., FCCP


Pediatr Pharm. 2002;8(2) 

In This Article


Pediatric Pharmacotherapy will focus on new pharmacologic approaches to the treatment of attention-deficit/hyperactivity disorder (ADHD).a This issue will focus on the use of methylphenidate, the most commonly used stimulant medication for ADHD, and highlight findings from the recently published National Institute of Mental Health (NIMH) multimodal treatment study. In addition, the availability of new dosage formulations will be addressed.

aThese reviews have been developed for a workshop on therapies for behavioral illnesses in children to be given at the 22 nd Annual University of Virginia McLemore Birdsong Pediatric Conference from May 17 th through 19 th. For more information, please contact Shirley P. Newman, Conference Coordinator at 434-924-2554.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: